HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

rF-TRICOM vaccine

derived from fowlpox virus engineered to express B7.1, ICAM-1, and LFA-3 for treatment of cancer

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Recombinant Proteins: 2754
    - Synthetic Vaccines: 1073
      - rF-TRICOM vaccine: 1
Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Cancer Vaccines: 4052
      - rF-TRICOM vaccine: 1
    - Synthetic Vaccines: 1073
      - rF-TRICOM vaccine: 1
Biological Factors: 2472
- Antigens: 143924
  - Synthetic Vaccines: 1073
    - rF-TRICOM vaccine: 1

Experts

1.	Cheung, Kenneth: 1 article (05/2003)
2.	DeRaffele, Gail: 1 article (05/2003)
3.	Haskall, Ziv: 1 article (05/2003)
4.	Hesdorffer, Charles: 1 article (05/2003)
5.	Horig, Heidi: 1 article (05/2003)
6.	Kaufman, Howard L: 1 article (05/2003)
7.	Panicali, Dennis: 1 article (05/2003)
8.	Spanknebel, Kathryn: 1 article (05/2003)

Related Diseases

1.	Neoplasms (Cancer) 05/20/2003 - "Intra-Lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer."